Companies in the genetics sector developing innovative solutions and technologies.
Explore 352 recently funded genetics companies with verified founder contact information and fundraising data.
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Canal Biosciences is a precision medicine company that offers DNA library preparation technologies for advanced genomics.
Kytopen develops genome engineering platforms that enable cell therapy research and manufacturing.
3X Genetics develops medical screening solutions to identify genetic disorders.
Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Tacit Therapeutics created RNA-targeting treatments for devastating diseases.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.
Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.
BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.
GenoGra is a biotechnology company that specializes in genomic analysis using software tools and bioinformatics.
Antarka develops Antarctic-derived enzymes that repair UV-damaged skin DNA, powering next-generation anti-aging and skin health solutions.
Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.
The Embryo Corporation is a biotech company that develops new organisms and biological traits using AI-driven genetic engineering.
Myrtelle is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders.
RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.
Feanix Biotechnologies is a genetic laboratory for testing samples.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 352 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked